Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive inborn disorder of cobalamin metabolism caused by biallelic variants in MMADHC. Depending on the type and location of variants in MMADHC, patients may present with methylmalonic aciduria, homocystinuria, or both. MMADHC has been reported to result in the cblD complementation group of cobalamin disorders.
Biomarker and diagnostic research for methylmalonic aciduria and/or homocystinuria, cblD type has been reported in the published literature.
No clinical trials have been registered for methylmalonic aciduria and/or homocystinuria, cblD type.
183 publications have been identified in PubMed for methylmalonic aciduria and/or homocystinuria, cblD type. Research spans Case Report / Case Series (32%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 59 | 32% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 7:58 AM UTC
Laboratory research |
34 |
19% |
Disease patterns and progression | 31 | 17% |
Testing and diagnosis research | 21 | 11% |
Research summaries | 18 | 10% |
Clinical study results | 13 | 7% |
New treatment approaches | 7 | 4% |
Zhao Z (2026). [PMID: 41691275](https://pubmed.ncbi.nlm.nih.gov/41691275/). *J Transl Med*. [Diagnostic / Biomarker]
Gokalp S (2026). [PMID: 42100905](https://pubmed.ncbi.nlm.nih.gov/42100905/). *Clin Dysmorphol*. [Case Report / Case Series]
Bayrak H (2026). [PMID: 41717433](https://pubmed.ncbi.nlm.nih.gov/41717433/). *In Silico Pharmacol*. [Basic Science / Preclinical]
Ardisasmita AI (2026). [PMID: 41806328](https://pubmed.ncbi.nlm.nih.gov/41806328/). *Journal of inherited metabolic disease*. [Basic Science / Preclinical]
Wasim M (2026). [PMID: 41776364](https://pubmed.ncbi.nlm.nih.gov/41776364/). *Pediatr Res*. [Epidemiology / Natural History]
Zhao HY (2026). [PMID: 42130361](https://pubmed.ncbi.nlm.nih.gov/42130361/). *Zhongguo Dang Dai Er Ke Za Zhi*. [Case Report / Case Series]
Saini AG (2026). [PMID: 42158251](https://pubmed.ncbi.nlm.nih.gov/42158251/). *Front Nutr*. [Review / Meta-Analysis]
Jorge LG (2026). [PMID: 42244747](https://pubmed.ncbi.nlm.nih.gov/42244747/). *bioRxiv*. [Basic Science / Preclinical]
Li MJ (2026). [PMID: 41371076](https://pubmed.ncbi.nlm.nih.gov/41371076/). *Mol Genet Metab*. [Epidemiology / Natural History]
Ding Y (2026). [PMID: 42135235](https://pubmed.ncbi.nlm.nih.gov/42135235/). *Zhonghua Er Ke Za Zhi*. [Epidemiology / Natural History]